Elevated Liver Enzymes With Positive Hepatitis B Serology After Intravenous Immunoglobulin Treatment of Guillain-Barré Syndrome-Reference-Cited by-同舟云学术

Elevated Liver Enzymes With Positive Hepatitis B Serology After Intravenous Immunoglobulin Treatment of Guillain-Barré Syndrome

Published:2023-12 Issue:12 Volume:10 Page:e01207
ISSN:2326-3253
Container-title:ACG Case Reports Journal
language:en
Short-container-title:ACG Case Rep J

Author:

Patel Shivam¹,Le Kim Minh Ngoc²,Puskoor Sujith³,Amaning Judith²

Affiliation:

1. Texas A&M University School of Medicine, Bryan, TX

2. Department of Gastroenterology, Baylor Scott & White Medical Center Round Rock, Round Rock, TX

3. Department of Internal Medicine, Baylor Scott & White Medical Center Round Rock, Round Rock, TX

Abstract

ABSTRACT Intravenous immunoglobulin (IVIG) is used to treat multiple conditions, one of which is Guillain-Barré syndrome. Despite its multiple benefits, IVIG can cause a wide variety of side effects, most of which resolve with supportive care. We present a case in which a patient with new-onset Guillain-Barré syndrome was treated with IVIG and subsequently developed an acute elevation in liver enzymes with positive hepatitis B serology.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference10 articles.

1. Guillain-Barre Syndrome;Malek;Semin Neurol,2019

2. Guillain-Barré Syndrome: Pathogenesis, diagnosis, treatment and prognosis;van den Berg;Nat Rev Neurol,2014

3. Adverse Effects of Immunoglobulin Therapy;Guo;Front Immunol,2018

4. Intravenous immunoglobulin-associated elevation of liver enzymes in neurological autoimmune disorder: A case series;Behera;Cureus,2020

5. Efficacy, safety, and pharmacokinetics of a 10% liquid immune globulin preparation (GAMMAGARD LIQUID, 10%) administered subcutaneously in subjects with primary immunodeficiency disease;Wasserman;J Clin Immunol,2011